Home › Multiple Myeloma › Rhode Island › Providence
Multiple Myeloma clinical trials in Providence, RI
4 studies for Multiple Myeloma are looking for participants at sites in and around Providence (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RecruitingPhase 3
- Rhode Island Hospital, Providence
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Rodhe Island Hospital, Providence
- The Miriam Hospital, Providence
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
RecruitingPhase 3
- GSK Investigational Site, Providence
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
RecruitingPhase 1/2
- Rhode Island Hospital, Providence
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Rochester, MN23 studies
- Washington, DC22 studies
Other studies in Providence
- Ovarian Cancer15 studies
- Endometrial Cancer15 studies
- Obesity14 studies
- Cancer (all types)13 studies
- Non-Small Cell Lung Cancer12 studies
- Crohn's Disease12 studies
- Ulcerative Colitis11 studies
- Breast Cancer11 studies
- Acute Myeloid Leukemia10 studies
- Metastatic Cancer9 studies
- Alzheimer's Disease9 studies
- Overweight9 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.